Conventional treatment options for breast cancer include cytotoxic chemotherapy, selective estrogen receptor modulators, selective estrogen receptor degraders, cyclin-dependent kinase inhibitors and aromatase inhibitors. Here, ESR1 is linked to breast cancer.